Tabid, Dan Aiza .
HRN: 20-46-76 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
10/15/2023
AZITHROMYCIN 200MG/5ML, 15ML SUSPENSION (SUSP)
10/15/2023
10/19/2023
PO
2.5ml
OD
PCAP
Waiting Final Action
Indication: Empiric Type of Infection: Pneumonia Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes